Maestri Evan, Duszka Kalina, Kuznetsov Vladimir A
Department of Biochemistry and Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
Department of Biology, SUNY University at Buffalo, Buffalo, NY 14260, USA.
Cancers (Basel). 2021 Jun 25;13(13):3180. doi: 10.3390/cancers13133180.
Systems cancer biology analysis of calorie restriction (CR) mechanisms and pathways has not been carried out, leaving therapeutic benefits unclear. Using metadata analysis, we studied gene expression changes in normal mouse duodenum mucosa (DM) response to short-term (2-weeks) 25% CR as a biological model. Our results indicate cancer-associated genes consist of 26% of 467 CR responding differential expressed genes (DEGs). The DEGs were enriched with over-expressed cell cycle, oncogenes, and metabolic reprogramming pathways that determine tissue-specific tumorigenesis, cancer, and stem cell activation; tumor suppressors and apoptosis genes were under-expressed. DEG enrichments suggest telomeric maintenance misbalance and metabolic pathway activation playing dual (anti-cancer and pro-oncogenic) roles. The aberrant DEG profile of DM epithelial cells is found within CR-induced overexpression of Paneth cells and is coordinated significantly across GI tract tissues mucosa. Immune system genes (ISGs) consist of 37% of the total DEGs; the majority of ISGs are suppressed, including cell-autonomous immunity and tumor-immune surveillance. CR induces metabolic reprogramming, suppressing immune mechanics and activating oncogenic pathways. We introduce and argue for our network pro-oncogenic model of the mucosa multicellular tissue response to CR leading to aberrant transcription and pre-malignant states. These findings change the paradigm regarding CR's anti-cancer role, initiating specific treatment target development. This will aid future work to define critical oncogenic pathways preceding intestinal lesion development and biomarkers for earlier adenoma and colorectal cancer detection.
尚未对卡路里限制(CR)机制和途径进行系统癌症生物学分析,其治疗益处尚不清楚。通过元数据分析,我们研究了正常小鼠十二指肠黏膜(DM)对短期(2周)25%卡路里限制的反应中的基因表达变化,以此作为生物学模型。我们的结果表明,癌症相关基因占467个对CR有反应的差异表达基因(DEG)的26%。这些DEG在决定组织特异性肿瘤发生、癌症和干细胞激活的细胞周期、癌基因和代谢重编程途径的过表达中富集;肿瘤抑制因子和凋亡基因表达不足。DEG富集表明端粒维持失衡和代谢途径激活发挥双重(抗癌和促癌)作用。DM上皮细胞异常的DEG谱在CR诱导的潘氏细胞过表达中发现,并在胃肠道组织黏膜中显著协调。免疫系统基因(ISG)占总DEG的37%;大多数ISG被抑制,包括细胞自主免疫和肿瘤免疫监视。CR诱导代谢重编程,抑制免疫机制并激活致癌途径。我们引入并论证了我们的黏膜多细胞组织对CR反应的网络促癌模型,该模型导致异常转录和癌前状态。这些发现改变了关于CR抗癌作用的范式,启动了特定治疗靶点的开发。这将有助于未来的工作,以确定肠道病变发展之前的关键致癌途径以及早期腺瘤和结直肠癌检测的生物标志物。